new glp-1 drugs in development What is the pipeline for future medications for obesity? GLP-1 Pipeline Update: February 2025

The lower price point and the approachability of a pill versus a shot opens up the market to casually interested patients, said BMO Capital Markets analyst Evan David Seigerman

While current data do not suggest adverse safety signals with GLP1 receptor agonists, more research is needed to fully understand their effects

In recent years, glucagon-like peptide-1 (GLP-1) receptor agonists have been used to control blood glucose levels in patients with diabetes

Heart Fail Clin

[DOI] [PMC free article] [PubMed] [Google Scholar] 38.Nanus DE, Filer AD, Hughes B, Fisher BA, Taylor PC, Stewart PM, Buckley CD, McInnes I, Cooper MS, Raza K